Hong Kong-listed AI drug discovery firm Insilico Drugs and Eli Lilly signal a drug co-development deal price as much as $2.75B, with $115M in upfront funds (Evelyn Cheng/CNBC)
Featured Podcasts Lenny's Podcast: From skeptic to true believer: How OpenClaw modified my life | Claire Vo Interviews with world-class ...
